Online
|
|
Auro near term target=900....
Posted by :
ambrishkapoorPFIZER touched 1000 today, so no doubt that this script will be close to it or further ahead of it....
Auro near term target=900....
Posted by :
RamkiTechnically also charts are showing there is a symmetrical continuation triangle(bullish)on november 23.....the target given by kotak securities is 947-977...ROFL...
Auro near term target=900....
Posted by : PUNTERnext target 1100 by Dec expiry....
Auro near term target=900....
Posted by : Ramki
Dear radhika.........
Yeah..........She has given up day trading and that`s the reason she is not asking any queries........He....He....He....He....ROFL...
Auro near term target=900....
Posted by : radhika_nandlal
Well done Ramki, you are a patient long term investor. Well done. Keep going.
Has your sister given up daytrading? She asked me some queries 2 years back...
Auro near term target=900....
Posted by : marketmanRamki,the scrip is looking strong and the revenue is expected to become two billion dollars within two years.... analysts are super bullish in the counter at the moment.... though it has run up very fast to present levels,still undertone remains bullish with the back up of strong fundamentals and future plans.......
Auro near term target=900....
Posted by : Ramki
Dear marketman......
I bought some small quantity of this scrip@662 levels 0n 30-07-2007 for long term.......
I thought of offloading this scrip at present levels cause I thought this has run up a lot....After seeing ur message I am thinking to wait for some more time to offload this scrip@900 levels.......Regards...
Aurobindo can cross 1000 by next month
Posted by : ambrishkapoor
News Courtsey moneycontrol:
Aurobindo Pharma has inaugurated a Rs 150 crore drug manufacturing plant at its pharma SEZ in Hyderabad. It expects revenues to hit USD 2 billion by 2013. But what is the road ahead for the company in terms of expansion? What is the future of the licensing agreement Aurobindo has with Pfizer to sell generic drugs in 70 emerging countries and developed markets? PharmaAsiaNews` Vikas Dandekar spoke to the top honchos of both drug-makers about their plans.
Two very important meetings, one with David Simmons, Pfizer’s Established Products Business Unit (EPBU) President, who was visiting India and Ramaprasad Reddy, a person who has been very reticent - never on record, have expressed very strong conviction to their partnership as far as sourcing of formulations are concerned.
David Simmons says Pfizer is very bullish about sourcing products from India. What we have seen from Aurobindo and Claris Life Sciences may not be the end of it, probably Pfizer is still scanning companies at least to collaborate. I also put a question on biosimilars and what their strategy will be? It appears that spade work is still being done. There are lot of rumours about Pfizer buying stake in companies which probably is a little premature, but some amount of interest is definitely there in looking at companies, definitely from India.
As far as Aurobindo is concerned, the company has remained quiet for such a long time. It’s the first time that I have spoken to Ramaprasad Reddy. USD 2 billion is what the company is aiming to achieve in the next three calendar years. That is quite a strong growth going forward. Pfizer’s association will be a very key point.
Apart from that, the company will be looking at expanding into several other geographies. In Europe, it is very strongly present. The number of product filings for the next year is like to be 8 products a month, so that will be nearly 100 for the whole year. This is quite a lot and in terms of active pharmaceutical ingredients (API). Backward integration is where thecompany has scored well over other generic plays. So, a very strong future for both these companies and the association going forward. ...
NSE Announcements on Aurobindo Pharm
Posted by : MMB MessengerAurobindo Pharma Ltd has informed the Exchange regarding a press release dated November 23, 2009, titled "Aurobindo Pharma celebrates the inauguration of its formulations manufacturing facility (Unit VII) in Special Economic Zone, Hyderabad India". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Aurobindo Pharm
Posted by : MMB Messenger
Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated November 23, 2009 titled "Aurobindo Pharma celebrates the inauguration of its formulations manufacturing
facility (Unit VII) in Special Economic Zone, Hyderabad India"...
Auro near term target=900....
Posted by : marketmanBuying interest still there in the counter.......
Auro near term target=900....
Posted by : marketmanLooking strong at the moment.......
Auro near term target=900....
Posted by : marketman
The scrip may move up in coming sessions ahead of positive news....
The company is expected to give an eps of 90 for the calender year 2010 on the expanded equity with the recent merger of its subsidy....
Dollar at 45 rupees taken in this view.... if the rupee strengthen,will have to review the targets and opiions on this scrip.......
BSE Announcements on Aurobindo Pharm
Posted by : MMB MessengerAurobindo Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 18, 2009 to December 23, 2009 (both days inclusive) for the purpose of Payment of Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on December 23, 2009. ...
any one tell what is the target of aurobindo pharma
Posted by :
jyothiramanahaltsget of aurobindo pharma...
